InsidersTradesSigma
Follow the IMPEL PHARMACEUTICALS INC share price and the full directors' dealings record of the company, a listed issuer based in United States. Shares are listed on the US market, under the supervision of SEC (Form 4). The latest transaction was disclosed on 19 December 2023 (Cession). Among the most active insiders: Vivo Capital VIII, LLC. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
IMPEL PHARMACEUTICALS INC is a company focused on developing innovative treatments for neurological diseases. It aims to provide therapeutic solutions that enhance patients' quality of life.